Skip to main content
. 2016 Aug 18;7(8):e2340. doi: 10.1038/cddis.2016.242

Figure 8.

Figure 8

(a) The amount of released infectious viral particles is reduced in Bcl-XL−/− macrophages compared with wt during VACV infection. On day 7 of differentiation, wt or Bcl-XL−/− macrophages were infected with VACV (MOI=10) for 16 h. Plaque assay was performed to measure infectious virus particles using infected cells plus supernatant at 1 : 1000 dilution. The number of plaques was counted. Number of plaques from wt cells was set to 100%. Data show means/S.E.M. of eight independent experiments with duplicate samples each (***P=0.00005; two-tailed unpaired t-test). (b) Treatment with ABT-737 reduced the amount of released infectious viral particles during VACV infection in macrophages. On day 7 of differentiation, wt macrophages were infected with VACV (MOI=10) for 16 h. Then, 1 μM ABT-737 was added for additional 4 h where indicated. Plaque assay was performed to measure infectious virus particles using infected cells plus supernatant at 1 : 1000 dilution. The number of plaques was counted. Number of plaques from untreated cells was set to 100%. Data show means/S.E.M. of five independent experiments with duplicate samples each (***P=0.0006; two-tailed paired t-test)